Pulmonx Corp (NASDAQ: LUNG) on Friday, soared 13.64% from the previous trading day, before settling in for the closing price of $1.76. Within the past 52 weeks, LUNG’s price has moved between $1.47 and $9.37.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -19.80%. The company achieved an average annual earnings per share of -7.31%. With a float of $36.05 million, this company’s outstanding shares have now reached $40.74 million.
Considering the fact that the conglomerate employs 291 people, you should pay attention to its efficiency factor.
Pulmonx Corp (LUNG) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Pulmonx Corp is 11.54%, while institutional ownership is 84.49%. The most recent insider transaction that took place on Sep 02 ’25, was worth 15,437. In this transaction PRESIDENT AND CEO of this company sold 9,648 shares at a rate of $1.60, taking the stock ownership to the 358,967 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Chief Financial Officer & PAO sold 7,936 for $1.60, making the entire transaction worth $12,698. This insider now owns 208,489 shares in total.
Pulmonx Corp (LUNG) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.36 earnings per share (EPS) for the period topping the consensus outlook (set at -0.44) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.01% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Pulmonx Corp (LUNG) is currently performing well based on its current performance indicators. A quick ratio of 4.62 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Compared to the last year’s volume of 1.0 million, its volume of 24.41 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 26.40%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 21.99%, which indicates a significant decrease from 35.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.70, while its 200-day Moving Average is $3.91. Nevertheless, the first resistance level for the watch stands at $2.15 in the near term. At $2.31, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.51. If the price goes on to break the first support level at $1.79, it is likely to go to the next support level at $1.59. Now, if the price goes above the second support level, the third support stands at $1.43.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
Market capitalization of the company is 81.49 million based on 40,747K outstanding shares. Right now, sales total 83,790 K and income totals -56,390 K. The company made 23,860 K in profit during its latest quarter, and -15,170 K in sales during its previous quarter.
